BCM
CEMI

Bayesian Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bayesian Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57,400
Closed -$279K – 728
2020
Q3 		$279K Buy
+57,400
New +$272K 0.07% 362

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's CEMI Position: Q4 2020 in Review

Bayesian Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2020, closing a stake of 57,400 shares — an estimated $279K sold.

Bayesian Capital Management first reported a position in CEMI in Q3 2020 and held it in 1 quarter. The position peaked at $279K in Q3 2020. 77 funds tracked by Wall St. Rank hold CEMI as of Q4 2020.

  • Bayesian Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 57,400 Chembio diagnostics, Inc. shares in Q4 2020, an estimated $279K.
  • Bayesian Capital Management first reported a position in Chembio diagnostics, Inc. in Q3 2020 and held it in 1 quarter.
  • Bayesian Capital Management's Chembio diagnostics, Inc. position peaked at $279K in Q3 2020.
  • 77 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2020.

Based on Bayesian Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.